SecBot SecBot
SECBOTREPLAY Home › Report › SEPN

SEPN · Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer,…

Septerna, Inc. · 8-K filed Aug 25, 2026 at 08:15 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Aug 25, 2026 at 08:15 ET

Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026. Dr. Patni brings over 25 years of biopharmaceutical experience and a track record of 10 regulatory approvals, which is a positive signal for the company's clinical-stage pipeline execution. This is a routine executive hire for a clinical-stage biotech and does not include any financial data or guidance changes.

  • Septerna appointed Rajiv Patni, M.D., as Chief Medical Officer, effective August 24, 2026.
  • Dr. Patni has over 25 years of experience and has contributed to 10 regulatory agency approvals or label expansions.
  • He most recently served as CEO of Judo Bio and previously as CMO at Global Blood Therapeutics, Portola Pharmaceuticals, and Adamas Pharmaceuticals.
  • The filing contains no financial data, guidance, or material business updates.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access